The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2319-2327

  Jehle, Peter M ^a   Fussgaenger, Rolf D ^a   Kunze, Ulrike ^a   Dolderer, Manfred ^a   Warchol, Wojciech ^c   Koop, Irmtraut ^b  

^a UNIVERSITY OF ULM   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c University of Posen   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN DERIVATIVE; INSULIN I 125; INSULIN RECEPTOR; ISOPHANE INSULIN; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONOCYTE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CELL LINE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; EATING; FEMALE; HUMANS; INSULIN; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; RECEPTOR, INSULIN;

EID: 0029946952     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2319     Document Type: Article

References (32)

1. Bhaskar R, Chou MCY, Field JB. 1980 Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. J Clin Endocrinol Metab. 50:475-479.
2. DiMarchi RD, Mayer JP, Fan L et al. 1992. Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor 1. In: Smith JA, Rivier JE, eds. Peptides: chemistry and biology, Proceedings of the Twelfth American Peptide Symposium. Leiden: ESCOM; 26-28.
3. B29-human insulin. Structure. 3:615-622.
4. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. 1994 [Lys(B28), Pro (B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes. 43:396-402.
5. Slieker LJ, Sundel K. 1991 Modification in the 28-29 position of the insulin B-chain alters binding to the IGF-I receptor with minimal effect on insulin receptor binding [Abstract]. Diabetes. 40(Suppl 1):A168.
6. Shaw WN, Su KSE. 1991 Biological aspects of a new human insulin analog: [Lys(B28),Pro(B29)]-human insulin [Abstract]. Diabetes. 40(Suppl 1):A464.
7. Radziuk J, Davies J, Pye R, DiMarchi R, Shields J, Chance R. 1992 Subcutaneous absorption of fast-acting insulin analogs: kinetics and bioeffectiveness [Abstract]. Diabetologia. 35(Suppl 1):A3.
8. Gavin III JR, Roth J, Neville Jr DM, DeMeyts P, Buell DN. 1974 Insulin-dependent regulation of insulin receptor concentrations. A direct demonstration in cell culture. Proc Natl Acad Sci USA. 71:84-88.
9. Olefsky JM. 1976 The insulin receptor. Its role in insulin resistance of obesity and diabetes. Diabetes. 25:1154-1157.
10. Böyum A. 1968 Separation of leukocytes from blood and bone marrow. Scand J Clin Invest. 21:77-89.
11. Schwartz RH, Bianco AR, Kahn werger BS, Kahn RC. 1975 Demonstration that monocytes rather than lymphocytes are the insulin binding cells in preparations of human peripheral blood mononuclear leukocytes: implications for studies of insulin resistant states in man. Proc Natl Acad Sci USA. 72:474-478.
12. Forsayeth JR, Montemurro A, Maddux BA, DePirro R, Goldfine ID. 1987 Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J Biol Chem. 262:4134-4140.
13. Jacobs S, Cook S, Svoboda ME, Van Wyk JJ. 1986 Interaction of the monoclonal antibodies alphaIR-1 and alphaIR-3 with insulin and somatomedin-C receptors. Endocrinology. 118:223-226.
14. Cheng YC, Prusoff WH. 1979 Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol. 22:3099-3108.
15. McGonigle F, Neve KA, Molinoff PB. 1986 A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 30:329-337.
16. Scatchard G. 1949 The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 51:660-672.
17. Bar RS, Gordon P, Roth J, Kahn CR, DeMeyts P. 1976 Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients. J Clin Invest. 58:1123-1135.
18. Reichard P, Nilsson BY, Rosenqvist U. 1993 The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 329:304-309.
19. Diabetes Control and Complication Trial Research Group. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:977-986.
20. Lean MJE, Ng LL, Tennison BR. 1985 Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J. 290: 105-108.
21. Heinemann L, Starke AAR, Heding L, Jensen I, Berger M. 1990 Action profiles of fast onset insulin analogues. Diabetologia. 33:384-386.
22. Kahn CR, Flier JS, Bar RS, et al. 1976 The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 294: 739-745.
23. Kosmakos FC, Roth J. 1980 Insulin-induced loss of insulin receptor in IM-9 lymphocytes. J Biol Chem. 255:9860-9869.
24. Jehle PM, Holl RW, Fußgänger RD, et al. 1995 Correlation of insulin resistance in type-II diabetes with reduced binding affinity of insulin receptors [Abstract]. Diabetologia. 38(Suppl 1):A79.
25. DeFronzo RA, Hendler R, Simonson D. 1982 Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes. 31:795-801.
26. DeFronzo RA, Simonson D, Ferannini E. 1982 Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 23:313-319.
27. Del Prato S, Nosadini R, Tiengo A, et al. 1983 Insulin-mediated glucose disposal in type 1 diabetes: evidence for insulin resistance. J Clin Endocrinol Metab. 57:904-910.
28. Sturis J, Scheen AJ, Leproult R, Polonsky KS, Van Cauter E. 1995 24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations. J Clin Invest. 95:1464-71.
29. Yki-Järvinen H, Helve E, Koivisto VA. 1987 Hyperglycemia decreases glucose uptake in type 1 diabetes. Diabetes. 36:892-896.
30. Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H. 1992 Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes. 41:571-580.
31. Rossetti L, Giaccari A, DeFronzo RA. 1990 Glucose toxicity. Diabetes Care. 13:610-630.
32. Vignati L, Anderson JH, Brunelle RL, Jefferson FL, Richardson M. 1994 Improvement of glycemic control with the rapidly absorbed lispro insulin analog in type I diabetes [Abstract]. Diabetologia. 37(Suppl 1):A79.